Indications for antimicrobial prescribing in European nursing homes: results from a point prevalence survey

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F12%3A10125696" target="_blank" >RIV/00179906:_____/12:10125696 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11160/12:10125696

Výsledek na webu

<a href="http://onlinelibrary.wiley.com/doi/10.1002/pds.3196/pdf" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1002/pds.3196/pdf</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1002/pds.3196" target="_blank" >10.1002/pds.3196</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Indications for antimicrobial prescribing in European nursing homes: results from a point prevalence survey

Popis výsledku v původním jazyce

PURPOSE: In light of the emerging problem with multiresistant microorganisms in nursing homes (NHs), the European Surveillance of Antimicrobial Consumption NH subproject was set up to measure and describe antimicrobial use across Europe. The aim of thispaper was to investigate the indications for antimicrobial use and hence identify targets for quality improvement. METHODS: Data were obtained from a point prevalence survey conducted in 323 NHs across 21 European countries. A resident questionnaire hadto be completed for each resident receiving an antimicrobial, collecting data such as compound name and indication for antimicrobial prescribing. Four main indications for antimicrobial use were recorded: nasal decolonisation of methicillin-resistant Staphylococcus aureus (MRSA) carriage with mupirocin, prophylactic, empirical, and microbiologically documented treatments. The latter three treatment types were further subdivided according to the targeted infections. RESULTS: In total, 196

Název v anglickém jazyce

Indications for antimicrobial prescribing in European nursing homes: results from a point prevalence survey

Popis výsledku anglicky

PURPOSE: In light of the emerging problem with multiresistant microorganisms in nursing homes (NHs), the European Surveillance of Antimicrobial Consumption NH subproject was set up to measure and describe antimicrobial use across Europe. The aim of thispaper was to investigate the indications for antimicrobial use and hence identify targets for quality improvement. METHODS: Data were obtained from a point prevalence survey conducted in 323 NHs across 21 European countries. A resident questionnaire hadto be completed for each resident receiving an antimicrobial, collecting data such as compound name and indication for antimicrobial prescribing. Four main indications for antimicrobial use were recorded: nasal decolonisation of methicillin-resistant Staphylococcus aureus (MRSA) carriage with mupirocin, prophylactic, empirical, and microbiologically documented treatments. The latter three treatment types were further subdivided according to the targeted infections. RESULTS: In total, 196

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FR - Farmakologie a lékárnická chemie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Pharmacoepidemiology and Drug Safety

ISSN

1053-8569

e-ISSN

—

Svazek periodika

21

Číslo periodika v rámci svazku

9

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

8

Strana od-do

937-944

Kód UT WoS článku

000308295000004

EID výsledku v databázi Scopus

—